Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)

NCT06991465 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Carcinoma

Interventions

RADIATION: Radiation Therapy
DRUG: FOLFOX regimen
DRUG: Capecitabine

Sponsor

Neil Kopek

Collaborators

[object Object]